share_log

Insiders Were the Key Beneficiaries as Mingchen Health Co.,Ltd.'s (SZSE:002919) Market Cap Rises to CN¥3.2b

Insiders Were the Key Beneficiaries as Mingchen Health Co.,Ltd.'s (SZSE:002919) Market Cap Rises to CN¥3.2b

隨着名臣健康股份有限公司(SZSE:002919)市值達到32億元,內部人士成爲了關鍵受益者。
Simply Wall St ·  08/05 20:49

Key Insights

主要見解

  • Insiders appear to have a vested interest in Mingchen HealthLtd's growth, as seen by their sizeable ownership
  • The top 4 shareholders own 51% of the company
  • 22% of Mingchen HealthLtd is held by Institutions
  • 內部人似乎對名臣健康有着旺盛的增長興趣,這可從他們的大規模股權持有看出。
  • 前4個股東擁有公司的51%股權。
  • 名臣健康有限公司的22%股份由機構持有。

A look at the shareholders of Mingchen Health Co.,Ltd. (SZSE:002919) can tell us which group is most powerful. We can see that individual insiders own the lion's share in the company with 49% ownership. That is, the group stands to benefit the most if the stock rises (or lose the most if there is a downturn).

看一下名臣健康有限公司(深圳證券交易所:002919)的股東情況可以告訴我們哪個群體最強大。我們可以看到,個人內部人持有公司的大部分股權,佔有49%。也就是說,如果股票上漲(或者市場出現下行),該群體將獲益最多(或者損失最大)。

As a result, insiders scored the highest last week as the company hit CN¥3.2b market cap following a 14% gain in the stock.

由於該公司股價上漲14%,市值達到32億元人民幣,內部人士上週獲得最高分。

In the chart below, we zoom in on the different ownership groups of Mingchen HealthLtd.

在下面的圖表中,我們放大了名臣健康股份有限公司的不同所有權團體。

big
SZSE:002919 Ownership Breakdown August 6th 2024
深證002919 所有權拆分 2024年8月6日

What Does The Institutional Ownership Tell Us About Mingchen HealthLtd?

機構所有權告訴我們有關名臣健康股份有限公司的什麼信息?

Institutional investors commonly compare their own returns to the returns of a commonly followed index. So they generally do consider buying larger companies that are included in the relevant benchmark index.

機構投資者通常將自己的回報與常見的指數回報進行比較。因此,他們通常會考慮購買包括在相關基準指數中的較大公司。

We can see that Mingchen HealthLtd does have institutional investors; and they hold a good portion of the company's stock. This can indicate that the company has a certain degree of credibility in the investment community. However, it is best to be wary of relying on the supposed validation that comes with institutional investors. They too, get it wrong sometimes. It is not uncommon to see a big share price drop if two large institutional investors try to sell out of a stock at the same time. So it is worth checking the past earnings trajectory of Mingchen HealthLtd, (below). Of course, keep in mind that there are other factors to consider, too.

我們可以看到,名臣健康股份有限公司確實有機構投資者,並且他們持有公司的相當大一部分股份。這可能表明該公司在投資社區中具有一定的信譽度。但是,最好對依賴機構投資者所提供的所謂驗證持謹慎態度。他們也會犯錯。如果兩家大型機構投資者嘗試同時拋售股票,股價大幅下跌並不罕見。因此,檢查名臣健康股份有限公司的過去收益軌跡(如下)是值得的。當然,也要記住還有其他因素需要考慮。

big
SZSE:002919 Earnings and Revenue Growth August 6th 2024
深市:002919盈利和收入增長2024年8月6日

Hedge funds don't have many shares in Mingchen HealthLtd. Our data shows that Qinfa Chen is the largest shareholder with 35% of shares outstanding. China Asset Management Co. Ltd. is the second largest shareholder owning 5.9% of common stock, and Xinling Wu holds about 5.5% of the company stock.

對於名臣健康有限公司,對沖基金並不持有太多股份。我們的數據顯示,陳勤發是最大的股東,持有35%的流通股。中國資產管理股份有限公司是第二大股東,擁有5.9%的普通股,吳新玲持有公司股份的約5.5%。

To make our study more interesting, we found that the top 4 shareholders control more than half of the company which implies that this group has considerable sway over the company's decision-making.

爲了使我們的研究更有趣,我們發現前四名股東控制了公司一半以上的股份,這意味着該集團對公司的決策具有相當大的影響力。

While studying institutional ownership for a company can add value to your research, it is also a good practice to research analyst recommendations to get a deeper understand of a stock's expected performance. As far as we can tell there isn't analyst coverage of the company, so it is probably flying under the radar.

儘管研究公司的機構所有權可以爲您的研究增加價值,但還是研究分析師的建議,以深入了解股票預期表現,是一個好習慣。就我們所知,該公司沒有分析師覆蓋,因此可能沒有引起注意。

Insider Ownership Of Mingchen HealthLtd

名臣健康股份有限公司的內部人員所有權

While the precise definition of an insider can be subjective, almost everyone considers board members to be insiders. Management ultimately answers to the board. However, it is not uncommon for managers to be executive board members, especially if they are a founder or the CEO.

雖然內部人員的精確定義可能具有主觀性,但幾乎所有人都認爲董事會成員是內部人員。管理層最終向董事會負責。然而,如果經理是創始人或CEO,那麼他們成爲執行董事會成員並不罕見。

Most consider insider ownership a positive because it can indicate the board is well aligned with other shareholders. However, on some occasions too much power is concentrated within this group.

大多數人認爲內部所有權是積極的,因爲它可以表示董事會與其他股東的利益相一致。但是,在某些場合下,這個團體的權力過於集中。

It seems insiders own a significant proportion of Mingchen Health Co.,Ltd.. It has a market capitalization of just CN¥3.2b, and insiders have CN¥1.6b worth of shares in their own names. This may suggest that the founders still own a lot of shares. You can click here to see if they have been buying or selling.

看起來,名臣健康股份有限公司的內部人士擁有相當大比例的股份。其市值僅爲32億人民幣,內部人士擁有價值16億人民幣的股份。這可能意味着創始人仍擁有大量股份。您可以點擊這裏查看他們是否一直在買入或賣出。

General Public Ownership

一般大衆所有權

With a 24% ownership, the general public, mostly comprising of individual investors, have some degree of sway over Mingchen HealthLtd. This size of ownership, while considerable, may not be enough to change company policy if the decision is not in sync with other large shareholders.

擁有24%的股權,大部分由個人投資者組成的普通公衆對名臣健康股份有限公司有一定的影響力。儘管這樣的持股比例相當可觀,但如果決策與其他大股東不同步的話,可能不足以改變公司政策。

Private Company Ownership

私有公司的所有權

It seems that Private Companies own 4.5%, of the Mingchen HealthLtd stock. Private companies may be related parties. Sometimes insiders have an interest in a public company through a holding in a private company, rather than in their own capacity as an individual. While it's hard to draw any broad stroke conclusions, it is worth noting as an area for further research.

名臣健康股份有限公司的股份中,私人公司擁有4.5%。私人公司可能是相關方。有時,內部人士通過持有私人公司的股份對一家上市公司產生興趣,而不是以個人的身份。雖然很難得出任何概括性的結論,但值得注意的是這個領域需要進一步研究。

Next Steps:

下一步:

It's always worth thinking about the different groups who own shares in a company. But to understand Mingchen HealthLtd better, we need to consider many other factors. Take risks for example - Mingchen HealthLtd has 1 warning sign we think you should be aware of.

思考不同的股東群體對一家公司擁有股份的意義總是值得的。但要更好地了解名臣健康股份有限公司,我們需要考慮許多其他因素。例如,承擔風險——名臣健康股份有限公司有1個警告信號,我們認爲您應該了解。

Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of interesting companies.

當然,您可能會在其他地方找到一項出色的投資。因此,請查看此免費的有趣公司列表。

NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.

注:本文中的數據是使用最後一個財務報表日期結束的爲期12個月的數據計算的。這可能與全年年度報告數據不一致。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對本文有任何反饋?對內容有任何疑慮?請直接與我們聯繫。或者,發送電子郵件至editorial-team@simplywallst.com。
這篇文章是Simply Wall St的一般性文章。我們根據歷史數據和分析師預測提供評論,只使用公正的方法論,我們的文章並不意味着提供任何金融建議。文章不構成買賣任何股票的建議,也不考慮您的目標或您的財務狀況。我們的目標是帶給您基本數據驅動的長期關注分析。請注意,我們的分析可能不考慮最新的價格敏感公司公告或定性材料。Simply Wall St沒有任何股票頭寸。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

對本文有任何反饋?對內容有任何疑慮?請直接與我們聯繫。或者,發送電子郵件至editorial-team@simplywallst.com。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論